e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Longeveron Inc. - Class A Common stock (NQ:LGVN)

1.900 -0.250 (-11.63%)

Delayed Quote Updated: 12:19 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Longeveron Inc. - Class A Common stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

3 Moonshot Stocks For 2022 ↗

February 16, 2022

Insider trading can be highly revealing when looking for moonshot stocks to buy. Here's three with insiders buying worth looking at.

Via InvestorPlace

Two Insider Moonshots Rising on Sudden Buying ↗

February 10, 2022

Biotech insiders are among the most important investors to pay close attention to. Here are two that show good signs for the future.

Via InvestorPlace

3 Stocks Insiders Are Buying on Market Turbulence ↗

January 27, 2022

When insiders buy a stock, you should take it as a sign that they think good news is about to come out. Here are three to watch closely.

Via InvestorPlace

41 Biggest Movers From Yesterday ↗

January 27, 2022

Gainers Ebang International Holdings Inc. (NASDAQ: EBON) shares gained 35.4% to settle at $1.09 on Wednesday as investors weighed the Federal Reserve Reserve decision to leave...

Via Benzinga

53 Biggest Movers From Friday ↗

January 24, 2022

Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares climbed 100% to close at $3.80 on Friday after gaining around 9% on Thursday. Dave Inc. (NASDAQ: DAVE) jumped 30.3% to settle...

Via Benzinga

34 Stocks Moving In Friday's Mid-Day Session ↗

January 21, 2022

Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares jumped 180% to $5.32 after gaining around 9% on Thursday. Bon Natural Life Limited (NASDAQ: BON) shares gained 22% to $3.91....

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 21, 2022

Good morning, investor! Let's close out the week right with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

18 Stocks Moving in Friday's Pre-Market Session ↗

January 21, 2022

Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares rose 422% to $9.93 in pre-market trading after gaining around 9% on Thursday. Barfresh Food Group Inc. (...

Via Benzinga

33 Stocks Moving In Thursday's Mid-Day Session ↗

January 06, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) shares jumped 50.8% to $6.88 after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe...

Via Benzinga

58 Biggest Movers From Yesterday ↗

January 07, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-...

Via Benzinga

This Company Is On a Mission to Level the Playing Field for Retail Investors ↗

January 06, 2022

Image provided by BlackBoxStocks The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

Why Longeveron Shares Are Rising Today ↗

January 05, 2022

Longeveron Inc (NASDAQ: LGVN) is trading higher Wednesday after the company announced initiation of the Phase 2a clinical trial of lomecel-B for the treatment of Alzheimer...

Via Benzinga

Alzheimer’s Disease Expected to Triple by 2050 While the Development Process for Potential Drug Candidates Increases

January 05, 2022

Palm Beach, FL – January 5, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an...

Via FinancialNewsMedia

Topics Death

Exclusive: Longeveron Kickstarts Its Mid-Stage Alzheimer's Disease Trial ↗

January 05, 2022

Longeveron Inc (NASDAQ: LGVN) has initiated its Phase 2a clinical trial evaluating Lomecel-B for Alzheimer’s disease (AD). The first patient has consented to...

Via Benzinga

25 Stocks Moving In Tuesday's Mid-Day Session ↗

December 28, 2021

Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 64.6% to $18.99 as traders circulated a social media post on a potential short squeeze. Flotek Industries, Inc. (NYSE...

Via Benzinga

54 Biggest Movers From Thursday ↗

December 27, 2021

Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

December 23, 2021

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK....

Via Benzinga

5 Short Squeeze Candidates To Watch: Petros Pharmaceuticals, iSpecimen Top The List Again ↗

December 20, 2021

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge movie. GameStop Corp (NY...

Via Benzinga

The 10 Most Shorted Stocks Right Now for Friday, Dec. 17 ↗

December 17, 2021

Shorted stocks continue to be of interest to retail traders looking for the next big day trade and we're diving into some top candidates!

Via InvestorPlace

Systemic Mastocytosis Treatments Gain Hope Due To Increasing Novel Treatment Options

December 21, 2021

Palm Beach, FL –December 21, 2021 – FinancialNewsMedia.com News Commentary – Systemic mastocytosis is rare disease which affects very few people and it causes due to C-kit mutation which leads to...

Via FinancialNewsMedia

Longeveron Inc. (NASDAQ:LGVN) Long Term Investor Notice: Investigation of Potential Wrongdoing ↗

December 17, 2021

San Diego, CA -- (SBWIRE) -- 12/17/2021 -- An investigation on behalf of current long-term investors in shares of Longeveron Inc. (NASDAQ:LGVN) concerning potential breaches of fiduciary duties by...

Via SBWire

5 Short Squeeze Candidates To Watch: Petros Pharma Tops List With 254% Cost To Borrow, One Of Highest Figures On Record ↗

December 13, 2021

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE: GME) and AMC Entertainment Holdings (NYSE: AMC...

Via Benzinga

3 Predictions for the Stock Market in 2022 ↗

December 10, 2021

Precisely predicting what the market will do is an easy way to get everything wrong, but here are three trends to look for in 2022.

Via InvestorPlace

Why Longeveron’s Good News Isn’t Telling Us the Whole Truth ↗

December 10, 2021

LGVN stock has soared in 2021 with the latest upbeat FDA news but a closer look at Longeveron's financials tells a different story.

Via InvestorPlace

Topics Initial Public Offering

18 Stocks Moving in Friday's Pre-Market Session ↗

December 10, 2021

Gainers Context Therapeutics Inc. (NASDAQ: CNTX) rose 48.6% to $9.30 in pre-market trading as the company announced data from ONA-XR in early breast cancer. The company said ONA-...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; US Initial Jobless Claims Drop To 52-Year Low ↗

December 09, 2021

Following the market opening Thursday, the Dow traded down 0.22% to 35,676.45 while the NASDAQ fell 0.30% to 15,740.38. The S&P also fell, dropping 0.21% to 4,691.18. The U.S...

Via Benzinga

Topics Stocks

Systemic Lupus Erythematosus Treatment Market Projected To Reach $3.56 Billion By 2027

December 08, 2021

Palm Beach, FL –December 8, 2021 – FinancialNewsMedia.com News Commentary – Systemic Lupus Erythematosus is also known as lupus. It is an autoimmune disease that affects all parts of your body. The...

Via FinancialNewsMedia

7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts ↗

December 07, 2021

These seven drug stocks, a mix of growth, value, and moonshot plays, each stand to see big moves in the next twelve months.

Via InvestorPlace

2 Big Stock Bets That Are Insiders Are Buying Now ↗

December 06, 2021

Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy.

Via InvestorPlace

Longeveron Granted Orphan Drug Designation by FDA for Lomecel-B to Treat Infants with Hypoplastic Left Heart Syndrome (HLHS) ↗

December 06, 2021

HLHS is a rare congenital heart defect that affects approximately 1,000 babies in the U.S. per year Orphan Drug Designation confers certain benefits and may result in...

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy